Molecular Mechanism and Progression of Primary Resistance to EGFR-TKI
- Analysis of 2 Cases

Molecular Mechanism and Progression of Primary Resistance to EGFR-TKI
- Analysis of 2 Cases

Tyrosine kinase inhibitor (TKI) have been proved to be effective in the treatment of advanced non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) sensitive mutation, which is superior to chemotherapy. However, there are still some patients with sensitive mutation...

Full description

Bibliographic Details
Main Authors: Meirong LIU, Fanlu MENG, Qing MA, Liyan GU, Diansheng ZHONG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2019-01-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
EGFR-TKI
Primary resistance
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2019.01.10

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2019.01.10

Similar Items